Cite
HARVARD Citation
Parseghian, C. et al. (2023). Resistance Mechanisms to Anti–Epidermal Growth Factor Receptor Therapy in RAS/RAF Wild-Type Colorectal Cancer Vary by Regimen and Line of Therapy. Journal of clinical oncology. 41 (3), pp. 460-471. [Online].